期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 27, 期 29, 页码 4827-4833出版社
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2009.22.7199
关键词
-
类别
资金
- Italian Association for Cancer Research
- Compagnia di S. Paolo
- CRT Foundation
- European Union [201279, 201640]
- Italian Ministry of University and Research, Regione Piemonte Ricerca Sanitaria Finalizzata
From the beginning of their lives, cancer cells exert a procoagulant activity in their microenvironment, which can extend systemically and become clinically evident as Trousseau's syndrome, the well-known association between tumor and thrombosis. It is becoming clear that the genetic mechanisms responsible for neoplastic transformation ( activation of oncogenes such as RAS or MET, and inactivation of tumor suppressor genes such as p53 or PTEN) directly induce the expression of genes controlling hemostasis. Activation of blood coagulation results in a selective advantage for cancer cells, as fibrin provides a scaffold for anchorage and invasion, and coagulation proteins induce receptor-mediated intracellular signals promoting invasive growth. Targeting the tumor procoagulant activity can fight not only a dangerous tumor adverse effect, but also the core mechanisms of cancer onset and progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据